FundingHealthcare & Life Sciences
ZeroHarm Sciences raises ₹65 crore Series A
By Abha Lohia · Editor ·
ZeroHarm Sciences: funding and every story →
Series AHyderabadFounded 2020
- ZeroHarm Sciences makes 100% plant-based health supplements using nano-formulation technology
- It raised ₹65 crore ($7.2 million) in Series A funding led by Kotak Alternate Asset Managers
- The company plans to build a health platform and expand internationally to the US, UK, and Middle East
What happened
- ZeroHarm Sciences raised ₹65 crore in Series A funding.
- The round was led by Kotak Alternate Asset Managers Limited via its Kotak Life Sciences Fund I, which invested ₹40 crore.
- Alkemi Growth Capital, a healthcare and consumer wellness-focused venture fund, participated with ₹25 crore.
- The company will use the funds to build a 'Trust over Promise' health platform that demonstrates supplement efficacy through measurable consumer health outcomes.
- Funds will also go toward national brand building and international expansion into the USA, UK, and Middle East.
- ZeroHarm Sciences also plans to scale its vertically integrated R&D and manufacturing ecosystem.
- Cipher-Plexus acted as the exclusive financial advisor for the transaction.
Why it matters
- India's nutraceutical market is projected to reach $18 billion by 2025.
- The global nutraceutical market is expected to cross $720 billion by 2027.
- Recent fundraises in the space include Elevate Now (₹18 crore) and Earthful (₹26 crore).
- The company's proprietary nano-formulation technology differentiates it from competitors like Kapiva, Plix, HealthKart, and Wellbeing Nutrition.
The business
- ZeroHarm Sciences is a Hyderabad-based vertically integrated nutraceutical company.
- It develops 100% plant-based health supplements using proprietary nano-formulation technology.
- The technology converts plant-derived nutrients into nano-sized particles to enhance bioavailability and enable controlled release at lower dosages.
- The company works with a network of over 10,000 farmers across Northeast India and the Himalayan region for medicinal plant sourcing.
- It controls the full value chain from cultivation to nano-processing.
- ZeroHarm Sciences has filed and received patents for multiple nano formulations, including turmeric-based phytochemicals, iron folic acid combinations, carotenoid-based eye health solutions, and synbiotic gut health compositions.
- Its portfolio includes over 60 SKUs across categories such as diabetes management, heart health, joint care, immunity, gut health, oncology support, women's wellness, and performance nutrition.
- Products are sold through its own website, Amazon, Flipkart, and quick commerce platforms.
- The company has served over 300,000 customers (3 lakh).
The founders
SD
Sachin Darbarwar
Co-founder and CEO- Co-founder and CEO of ZeroHarm Sciences.
SD
Shweta Darbarwar
Co-founder- Co-founder of ZeroHarm Sciences.
Who put in money
- Kotak Alternate Asset Managers Limited lead — Manages the Kotak Life Sciences Fund I, which invested ₹40 crore in this round.
- Alkemi Growth Capital participated — Healthcare and consumer wellness-focused venture fund that invested ₹25 crore.
In numbers
₹65 croreFunding raised · 2026
300,000Customers served · 2026
60+SKUs in portfolio · 2026
10,000+Farmer network · 2026
What happens next
- Build a 'Trust over Promise' health platform demonstrating supplement efficacy through measurable consumer health outcomes.
- Expand nationally with brand building initiatives.
- Enter international markets including the USA, UK, and Middle East.
- Scale the vertically integrated R&D and manufacturing ecosystem.
Up against
KapivaPlixHealthKartWellbeing Nutrition
Words to know
- nano-formulation
- A process that breaks down nutrients into extremely tiny particles (nanometers) to improve how well the body absorbs them.
- nutraceutical
- A food or supplement that provides health benefits, such as vitamins, minerals, or herbal extracts.
- SKU
- Stock Keeping Unit – a unique identifier for each product variant, used to track inventory.
- bioavailability
- The proportion of a nutrient that enters the bloodstream and can be used by the body.
The numbers around it
Healthcare & Life Sciences in February 2026: 18 rounds with a disclosed amount, $66.5 million in all; the biggest was Pandorum Technologies ($18M). Every sector this year →
Other articles talking about it
Terms in this story
- Funding stage: Startups raise money in steps called funding stages: pre-seed, seed, Series A, B, C and later, ending in a listing or a sale. Each step is larger and asks for more proof. In India, Series A rounds run from a few million dollars to about $15 million, as of November 2026.
- Series A: Series A is usually the first large round a startup raises from venture capital funds, after it has shown that people want what it sells. In India it commonly runs from a few million dollars to about $15 million, or roughly ₹25 crore to over ₹100 crore, with founders selling about 15 to 25 percent, as of November 2026.
- Lead investor: A lead investor is the investor that sets the price and main terms of a funding round, does the deepest checks on the company and usually puts in the largest cheque. When a headline says a round was led by a fund, that fund was the first to commit and shaped the deal that others joined.
Read next
FundingAugust AI raises $12M for US expansionAugust AI offers an AI health assistant that answers medical questions through WhatsApp and a mobile appFundingVitusCare raises $3 million Series BVitusCare runs dialysis units inside partner hospitals, which keeps costs low, and has grown from 22 to over 60 centresLaunchKapiva gives away Dia Free Juice on World Diabetes DayKapiva is a Bengaluru-based Ayurveda wellness brand selling herbal juices and supplements, with a flagship juice aimed at people managing blood sugar
Everything on ZeroHarm Sciences → · All startup news on 25 February 2026 →
Is this ZeroHarm Sciences? Get your “Featured on StopDown” badge →